After the decision to ban electronic cigarettes in Brazil, many people have been trying to understand the reasoning behind the ban and determine whether or not e-cigarettes are harmful.
In the face of the risks posed by electronic cigarettes, the singer duo Zé Neto and Cristiano, who hail from Brazil's countryside, have sparked a lot of curiosity due to Zé Neto's lung complications.
Electronic cigarettes are a type of oily solution containing nicotine that, like traditional cigarettes, can lead to chemical dependency.
With the support of Brazil's National Health Surveillance Agency (Anvisa), the Ministry of Justice has banned e-cigarettes. Anvisa's regulation has been in place since 2009, but in 2019, a regulatory process was launched to overturn the law.
However, in addition to maintaining the law, a clause has also been included that imposes a daily fine of 5,000 riyals on companies that continue to commercialize.
The Consumer Protection and Department of Defense cited electronic cigarettes as posing a risk to the well-being and health of consumers as the reason for their statement.
Furthermore, according to reports, the consumption of electronic cigarettes has experienced exponential growth in recent years, especially among young people.
One of the most well-known examples of the risks associated with e-cigarettes occurred with Brazilian singers Zé Neto and Cristiano, specifically with the former member of the duo, Zé Neto.
The singer experienced shortness of breath while singing and was diagnosed with "pulmonary ground-glass nodules" that required urgent treatment. Another term commonly used by experts to describe this condition is "ground-glass opacity.
The doctor claims that the issue was caused by e-cigarettes.
In a post on Instagram, Zeneito stated that he had to undergo treatment due to lung complications caused by using e-cigarettes.
Moreover, he has used his influence to warn fans about the dangers of e-cigarettes.
Sertanejo stated, "Due to e-cigarettes, I experienced severe pulmonary issues and I warn anyone using them to stop.
Statement:
This article is compiled from third-party information for industry communication and learning purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is solely for internal industry research and communication purposes.
Due to the limitations of the translation skills, the translated article may not fully reflect the original text. Therefore, please refer to the original text for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on all domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.
The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
